You are now leaving our website. Kindly note that this link is offered as a service and EVER is not responsible for any content published on the thirds-party website you are about to enter.
Clinical efficacy and patient benefits Several clinical pilot trials have been performed using Cerebrolysin in traumatic brain injury. Cerebrolysin was administered as an adjunctive…
Expert InterviewsInterview with Chief Investigator of Captain We asked the CAPTAIN key investigator Prof. Dafin Muresanu for an interview and discussed with him some topics like dosage regime of…
Download area - Stroke This page includes some information that is intended for registered useres only. If you would like to access this information please login.> General Cerebrolysin…
About Cerebrolysin Cerebrolysin is a multi-modal neuropeptide drug with a fast onset of action that helps to regain and maintain the independence of patients suffering from stroke, TBI, dementia and…
Terms of Use Last updated: 11.04.2018 1. Scope of Agreement 1.1. The use of the services on the non-public product sites on www.cerebrolysin.com ("Website") is offered to you by EVER Neuro…
Disclaimer EVER Pharma undertakes all appropriate effort to make correct and complete information available on this website, but assumes no responsibility, guarantees or liability whatsoever that…
